Navigation Links
The Year of Affordable Healthcare Brings Together San Francisco Community Groups to Tackle Healthcare Crisis
Date:5/28/2009

Local Roundtable First in a Series of Community Discussions on Improving Access to More Affordable Healthcare and Medicine

SAN FRANCISCO, May 28 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today held the first in a series of community roundtables as part of their Year of Affordable Healthcare campaign (www.yearofaffordablehealth.com). The event, held at the YMCA San Francisco, aimed at raising awareness of the need for access to more affordable healthcare and medicine for Americans nationwide. In attendance were a wide-range of community organizers, thought leaders, government officials, and members of the San Francisco community.

San Francisco City & County Supervisor Sean R. Elsbernd opened the event with remarks stressing the importance of programs in the city, like Healthy San Francisco and the work conducted by the Health Service System.

The forum was moderated by Pamela Gilbert, Partner at Cuneo Gilbert & LaDuca and former Executive Director of the Consumer Product Safety Commission and featured Janhavi Bonville of the National Multiple Sclerosis Society, Jeff Schindler of the Haight Ashbury Free Clinic, Erin Reedy of the YMCA San Francisco, and Doreen King-Roberts, the Community Convener for the Neighborhoods West of Twin Peaks. Topics of discussion included universal healthcare, rising costs in California, state healthcare reform needs, and the cost saving potential of biogenerics.

"With healthcare costs skyrocketing in the state of California, now it is more important than ever to bring together communities to discuss innovative solutions to this crisis that affects every American," said Pamela Gilbert.

Today's event is part of a larger drive by the Year of Affordable Healthcare to raise awareness of the need for more affordable healthcare and medicine for Americans. Subsequent community roundtables will be hosted by the Year of Affordable Healthcare this summer in both Chicago, Illinois and Philadelphia, Pennsylvania.

About the Year of Affordable Healthcare

The Year of Affordable Healthcare campaign (www.yearofaffordablehealth.com) is a nationwide call for increased access to affordable healthcare for American citizens. The program coincides with the 25th anniversary of the landmark Hatch-Waxman Act, which created the modern generic pharmaceutical industry and has saved billions of healthcare dollars.

About Teva USA

Teva USA is a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., one of the largest generic pharmaceutical companies in the world and among the top 20 pharmaceutical companies.


'/>"/>
SOURCE Teva Pharmaceuticals USA
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Security Officers Who Protect Kaiser Hospitals Rally With Community Supporters for Access to Affordable Healthcare
2. UCSF creates fast, affordable tool for finding gene on-off switches
3. Affordable and Flexible CRM Solutions - Key to Drive Investments from Pharmaceutical Companies, Notes Frost & Sullivan
4. Security Officers Who Guard Kaiser Hospitals Protest Lack of Access to Affordable Healthcare
5. From Practical to Pampering: CVS/pharmacy Offers a Wide Selection of Department Store-Quality Gifts at Affordable Prices for Mothers Day
6. New Walmart Program Broadens Access to Affordable Prescriptions in Michigan
7. As Kaiser Permanente Opens a New Hospital Wing, Security Officers Left Behind Without Affordable Healthcare
8. Community Approach Necessary For Affordable Long-Term Care, Says NCB Capital Impact
9. Lesson From the States: Lack of Cost Controls Derailed California Health Reform, Led to Budget Overruns and Unaffordable Policies in Massachusetts
10. Deerfield Spa, the Northeasts Most Affordable Destination Spa, Now Offers Day Spa Getaways
11. A $25 Sleeping Bag Incubator to Join More Than 40 Innovations at Extremely Affordable Health Innovations News Conference and Exhibit at 6th Annual World Health Care Congress, April 15, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... Qualis Health, one of the ... 8th Annual DecisionHealth Platinum Awards in recognition of its innovative healthcare management programs ... across multiple award categories, highlighting four of the organization’s current programs:, ...
(Date:2/17/2017)... , ... February 17, 2017 , ... ... operations executives and focusing on all facets of clinical trial planning and management. ... , patient engagement, and more. In addition, attendees stopping by Pharmica’s booth were ...
(Date:2/17/2017)... ... 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists from around the ... - 23 in Beaver Creek, CO. It was announced today by Cindy Lovelace, executive ... Beaver Creek, hosting over 60 faculty members and addressing unmet needs of the NET ...
(Date:2/16/2017)... ... February 17, 2017 , ... ... last long after their final treatments. Physician researchers at The Marcus Institute ... a mind-body therapy, for efficacy in reducing symptoms of traumatic stress in cancer ...
(Date:2/16/2017)... ... February 16, 2017 , ... Doctors on Liens is proud ... their network through his work at BKP Chiropractic in Lancaster . ... degree from Canada’s prestigious International Baccalaureate Program, Dr. Raj went on to open ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... , February 17, 2017 Cryoablation, Electrical, ... The global ablation technologies market is expected to grow ... from 2022-2027. The market is expected to grow at a CAGR ... $3.3bn in 2016, and $9.05bn in 2026. ... How this report will benefit you ...
(Date:2/17/2017)... , February 17, 2017 According to ... Particle Counters, Liquid Particle Counters), Application (Cleanroom Monitoring, Contamination Monitoring of ... to 2021" published by MarketsandMarkets, the market is expected to reach ... at a CAGR of 3.7% from 2016 to 2021. ... ...
(Date:2/17/2017)... 17, 2017 Theravance Biopharma, Inc. (NASDAQ: ... "Company") today announced the presentation of positive clinical ... administered pan-Janus kinase (JAK) inhibitor designed to be ... of the European Crohn,s and Colitis Organization (ECCO). ... data from its completed Phase 1 study of ...
Breaking Medicine Technology: